Foundation tier · Anti-Aging & Longevity
Rapamycin for Anti-Aging & Longevity
An mTOR inhibitor FDA-approved as an immunosuppressant, now studied for longevity applications.
Medical Disclaimer
Why Rapamycin for Anti-Aging & Longevity
Role in Protocol
mTOR inhibition for longevity
Evidence Note
The most robust longevity compound in preclinical research. The NIA Interventions Testing Program showed consistent lifespan extension in mice. Human data are limited to observational studies and small trials exploring intermittent low-dose protocols.
Literature Dosing
1-6 mg weekly oral -- ITP dosing data; human longevity dosing is investigational
Dosing Context
Longevity (Intermittent)
Dose
1–6 mg
Frequency
weekly
Transplant Immunosuppression (FDA-Approved)
Dose
2–15 mg
Frequency
daily
Often Used Alongside
Key Safety Notes
Hypersensitivity to sirolimus or derivatives
Allergic reactions documented.
Active untreated infections
Immunosuppressive at transplant doses; even at low doses, immune function is modulated.
Severe hepatic impairment
Rapamycin is hepatically metabolised via CYP3A4.
Full Rapamycin Profile →
Full Anti-Aging & Longevity Protocol →